Clinical TrialsSearch results
Number of results: 886
Other
- Establishment of surveillance system for the longstanding ulcerative colitis patients Comparative study of efficacy for the targeted biopsy and the step biopsy
- Ulcerative colitis
- Teikyo University School of Medicine
- 2009-01-05
Other
- Gemcitabine Plus Paclitaxel versus Gemcitabine alone in Patients with Recurrent or Advanced Urothelial Cancer previously Treated With Cisplatin-based Chemotherapy: A randomized Phase II study
- Urothelial cancer
- Teikyo University
- 2009-10-01
Other
- Neoadjuvant chemotherapy using the TXL and CDDP followed by surgery for advanced gastric cancer - Phase II
- advanced gastric cancer
- TC therapy for gastric cancer study group
- 2005-11-09
Recruiting
- Temozolomide as monotherapy for elderly and temozolomide sensitive glioblastoma
- glioblastoma
- Tateishi Kensuke
- 2021-03-24
Other
- Clinical trials to evaluate the efficacy and safety of Scleral contact lens,OPS01
- Corneal astigmatism that cannot use existing RGP contact lenses and soft contact lenses.
- Tasaka Tetsuya
- 2023-09-04
No Longer Recruiting
- Transient Elastgraphy fo pediatric patients with acute lymphoblastic leukemia to evaluate liver steatosis
- de novo acute lymphoblastic leukemia
- Tanoshima Reo
- 2021-04-22
Recruiting
- A Phase 2, Multicenter, Placebo-Controlled, Randomized, Double-Blind, 48-Week Study to Evaluate the Efficacy and Safety of Combination Therapy of K-877-ER and CSG452 in Patients with Noncirrhotic Nonalcoholic Steatohepatitis (NASH) with Liver Fibrosis
- NASH
- Tanigawa Ryohei
- 2023-04-29
Completed
- A Phase III Long Term Study of K-877 Extended Release Tablet
- Dyslipidemia
- Tanigawa Ryohei
- 2021-02-05
Other
- A Phase 3 trial of perioperative pembrolizumab or enfortumab vedotin in combination with pembrolizumab in participants who are cisplatin-ineligible or decline cisplatin with Muscle-Invasive Bladder Cancer
- Muscle-invasive Bladder Cancer
- Tanaka Yoshiyuki
- 2023-03-03
Recruiting
- Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)
- Non-muscle Invasive Bladder Cancer
- Tanaka Yoshiyuki
- 2021-03-01